Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| CEO | Davis J. E. | Sep 1, 2026 | Sell | $2.43M | 10,000 |
| SVP & General Counsel | PREVOZNIK MICHAEL E | Aug 28, 2026 | Sell | $3.89M | 16,010 |
| SVP & General Counsel | PREVOZNIK MICHAEL E | Aug 28, 2026 | Sell | $1.52M | 6,237 |
| SVP & General Counsel | PREVOZNIK MICHAEL E | Aug 28, 2026 | Sell | $105.14K | 430 |
| SVP & Chief Commercial Officer | DELANEY MARK E | Jul 28, 2026 | Sell | $376.29K | 1,600 |
| SVP for Diagnostic Services | Plewman Patrick | Mar 5, 2026 | Sell | $588.73K | 2,855 |
| SVP & General Counsel | PREVOZNIK MICHAEL E | Mar 5, 2026 | Sell | $799.68K | 3,878 |
| EVP, Regional Businesses | Doherty Catherine T. | Mar 5, 2026 | Sell | $1.15M | 5,558 |
| SVP, Clinical Solutions | KUPPUSAMY KARTHIK | Mar 4, 2026 | Sell | $538.37K | 2,628 |
| SVP for Diagnostic Services | Plewman Patrick | Mar 3, 2026 | Sell | $85.17K | 410 |
| EVP, Regional Businesses | Doherty Catherine T. | Mar 3, 2026 | Sell | $131.29K | 632 |
| SVP & General Counsel | PREVOZNIK MICHAEL E | Mar 3, 2026 | Sell | $109.27K | 526 |
| CEO | Davis J. E. | Mar 2, 2026 | Sell | $2.13M | 10,000 |
| SVP & General Counsel | PREVOZNIK MICHAEL E | Feb 19, 2026 | Sell | $227.57K | 1,111 |
| SVP for Diagnostic Services | Plewman Patrick | Feb 19, 2026 | Sell | $196.23K | 958 |
| EVP, Regional Businesses | Doherty Catherine T. | Feb 19, 2026 | Sell | $293.52K | 1,433 |
| EVP, Regional Businesses | Doherty Catherine T. | Feb 13, 2026 | Sell | $2.17M | 10,573 |
| EVP, Regional Businesses | Doherty Catherine T. | Feb 13, 2026 | Sell | $2.09M | 10,122 |
| EVP, Regional Businesses | Doherty Catherine T. | Feb 13, 2026 | Sell | $724.79K | 3,500 |
| EVP, Regional Businesses | Doherty Catherine T. | Feb 13, 2026 | Sell | $337.09K | 1,619 |
| EVP, Regional Businesses | Doherty Catherine T. | Feb 13, 2026 | Sell | $73.39K | 351 |
| SVP for Diagnostic Services | Plewman Patrick | Feb 10, 2026 | Sell | $1.16M | 5,662 |
| Director | Gregg Vicky B | Nov 25, 2025 | Sell | $239.7K | 1,250 |
| CEO | Davis J. E. | Nov 25, 2025 | Sell | $1.79M | 9,342 |
| CEO | Davis J. E. | Nov 25, 2025 | Sell | $7.88M | 41,004 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.
